ProQR Therapeutics BV (PRQR) has released an update.
ProQR Therapeutics N.V. reported a decrease in total assets from €137,883 thousand to €123,876 thousand between December 31, 2023, and March 31, 2024. The company’s total equity also dropped from €41,390 thousand to €34,821 thousand in the same period. Additionally, ProQR posted a loss of €7,658 thousand for the quarter ending March 31, 2024, an improvement from the €8,855 thousand loss in the comparable quarter of the previous year.
For further insights into PRQR stock, check out TipRanks’ Stock Analysis page.
